Inflammation markers predict increased weight gain in smoking quitters

Obesity Research

Volumn 11, Issue 11, 2003, Pages 1339-1344

  Duncan, Bruce B ^a,b   Schmidt, Maria Inês ^a,b   Chambless, Lloyd E ^b   Folsom, Aaron R ^c   Heiss, Gerardo ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b IL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Fibrinogen; Leukocytes; Smoking; Smoking cessation; Weight gain

Indexed keywords

BIOLOGICAL MARKER; FIBRINOGEN;

ARTICLE; BLOOD; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PHYSIOLOGY; RISK; SMOKING; SMOKING CESSATION; WEIGHT GAIN;

BIOLOGICAL MARKERS; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; ODDS RATIO; SMOKING; SMOKING CESSATION; WEIGHT GAIN;

EID: 1542545598     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.181     Document Type: Article

References (35)

1. O'Hara P, Connett JE, Lee WW, Nides M, Murray R, Wise R. Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol. 1998;148:821-30.
2. Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med. 1995;333:1165-70.
3. Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Carpenter M, Heiss G. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults - the ARIC study. Atherosclerosis Risk in Communities. Obes Res. 2000;8:279-86.
4. Duncan BB, Schmidt MI. Chronic activation of the innate immune system may underlie the metabolic syndrome. Sao Paulo Med J. 2001;119:122-7.
5. Everson SA, Goldberg DE, Helmrich SP, Lakka TA, Lynch JW, Kaplan GA et al. Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care. 1998;21:1637-43.
6. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1989;129:687-702.
7. Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiologic studies. Am J Clin Nutr. 1982;36:936-42.
8. National Heart Lung and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. Operations Manual, no. 7: Blood Collection and Processing, Version 1.0. Chapel Hill, NC: ARIC Study Coordinating Center, School of Public Health, University of North Carolina; 1987.
9. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study, I. Development of blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;61:15-9.
10. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-46.
11. Chambless LE, McMahon RI, Wu KK, Folsom AR, Finch A, Shen Y-L. Short-term intraindividual variability in hemostasis factors, the ARIC Study. Ann Epidemiol. 1992;2:723-33.
12. Walker JF, Collins LC, Rowell PP, Goldsmith LJ, Moffatt RJ, Stamford BA. The effect of smoking on energy expenditure and plasma catecholamine and nicotine levels during light physical activity. Nicotine Tob Res. 1999;1:365-70.
13. Perkins KA. Metabolic effects of cigarette smoking. J Appl Physiol. 1992;72:401-9.
14. Hodge AM, Westerman RA, de Courten MP, Collier GR, Zimmet PZ, Alberti KG. Is leptin sensitivity the link between smoking cessation and weight gain? Int J Obes Relat Metab Disord. 1997;21:50-53.
15. Assali AR, Beigel Y, Schreibman R, Shafer Z, Fainaru M. Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol. 1999;22:357-60.
16. Doherty K, Militello FS, Kinnunen T, Garvey AJ. Nicotine gum dose and weight gain after smoking cessation. J Consult Clin Psychol. 1996;64:799-807.
17. Miyata G, Meguid MM, Fetissov SO, Torelli GF, Kim HJ. Nicotine's effect on hypothalamic neurotransmitters and appetite regulation. Surgery. 1999;126:255-63.
18. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199-204.
19. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42-7.
20. Marette A. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care. 2002;5:377-83.
21. Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 2001;293:1673-7.
22. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420:333-6.
23. Spiegelman BM. PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes. 1998;47:507-14.
24. Akazawa S, Sun F, Ito M, Kawasaki E, Eguchi K. Efficacy of troglitazone on body fat distribution in type 2 diabetes. Diabetes Care. 2000;23:1067-71.
25. Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol. 2001;169:453-9.
26. Crook MA, Scott DA, Stapleton JA, Palmer RM, Wilson RF, Sutherland G. Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation. Eur J Clin Invest. 2000;30:861-5.
27. Mochida-Nishimura K, Surewicz K, Cross JV, et al. Differential activation of MAP kinase signaling pathways and nuclear factor-kappaB in bronchoalveolar cells of smokers and nonsmokers. Mol Med. 2001;7:177-85.
28. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384-8.
29. Libert C. Inflammation: a nervous connection. Nature. 2003;421:328-9.
30. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2:372-7.
31. Liu RH, Kurose T, Matsukura S. Oral nicotine administration decreases tumor necrosis factor-alpha expression in fat tissues in obese rats. Metabolism. 2001;50:79-85.
32. Hill AL, Roe DJ, Taren DL, Muramoto MM, Leischow SJ. Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample. Nicotine Tob Res. 2000;2:247-53.
33. Nordstrom BL, Kinnunen T, Utman CH, Garvey AJ. Long-term effects of nicotine gum on weight gain after smoking cessation. Nicotine Tob Res. 1999;1:259-68.
34. Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2003;52:1799-805.
35. Chu NF, Chang JB, Shieh SM. Plasma C-reactive protein concentrations in relation to 5-year body weight change among children: the Taipei Children Heart Study. Int J Obes Relat Metab Disord. 2003;27:735-9.